Treatment of Sarcoidosis with Localized Cutaneous Granulomatous Skin Lesions (Cosmetically Important Sites)
Clinical Scenario
This protocol addresses patients with cutaneous sarcoidosis presenting as specific granulomatous skin lesions that are few in number and localized in distribution, with involvement at cosmetically important sites.
Cutaneous sarcoidosis
Specific granulomatous lesions
Few & localized
Cosmetically important
Local vs. Systemic Considerations
When a patient has very few localized lesions, initial management may include topical or intralesional approaches. However, when lesions do not respond to local therapy or when skin disease is more generalized, systemic pharmacotherapy becomes necessary.
The systemic approach for this scenario involves corticosteroid-based therapy, with additional steroid-sparing agents considered for longer-term management to reduce exposure to corticosteroid side effects.
The complete regimen — including agent selection, sequencing, and full clinical criteria — is available in the structured protocol.
References
- If the patient has very few localized lesions, they may respond to application of a corticosteroid cream or intralesional injections.
- If lesions do not respond to local therapy or if skin disease is more generalized, some type of pharmacotherapy is required.
- Systemic corticosteroids are usually used at least for the short term, but because of their many potential side effects, other agents should be considered for longer-term treatment.
- Hydroxychloroquine is often the first steroid-sparing drug used.
- Among the cytotoxic drugs, methotrexate seems to have a better response rate than other agents.
- In some cases, derivatives of tetracycline have been helpful in mild disease.
View source ↗